InvestorsHub Logo

H2R

Followers 41
Posts 2200
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: None

Monday, 06/17/2024 11:45:28 AM

Monday, June 17, 2024 11:45:28 AM

Post# of 717269
Senti Flipper, could this study be one of them?

https://clinicaltrials.gov/study/NCT04348747

* Phase 2
* Checkpoint Inhibitor ( Pembrolizumab / Keytruda)
* Biological: Anti-HER2/HER3 Dendritic Cell Vaccine
* Principal Investigator:Shipra Gandhi,Roswell Park Cancer Institute

?

Best of luck to Patients, NWBO, and Longs!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News